Brief: Zentiva Says Amendeds Offer To Acquire Each Outstanding Share Of Apontis Pharma In Cash By Waiving Condition Of A Minimum Acceptance
19/11/2024 20:38
Nov 19 (Reuters) -
* ZENTIVA- AMENDEDS OFFER TO ACQUIRE EACH OUTSTANDING SHARE
OF
APONTIS PHARMA IN CASH BY WAIVING CONDITION OF A MINIMUM
ACCEPTANCE
Source text: ID:nEQ1xHG4ka
Further company coverage: APPHG.DE
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Apontis Pharma AG
See all newsBrief: Bruno Wohschlegel To Leave Apontis Pharma As CEO End Of August
Brief: APONTIS PHARMA Q1 EBITDA EUR 1.3 Million
Brief: Apontis Pharma Says Zentiva AG Submits Formal Request To Carry Out A Merger
Brief: Zentiva Says Amendeds Offer To Acquire Each Outstanding Share Of Apontis Pharma In Cash By Waiving Condition Of A Minimum Acceptance
Brief: Apontis Pharma: Zentiva To Launch Voluntary Public Purchase Offer At EUR 10.00 Per Share